Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection
- PMID: 32915194
- PMCID: PMC7489396
- DOI: 10.1001/jamacardio.2020.4916
Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection
Erratum in
-
Errors in Results and Table.JAMA Cardiol. 2021 Jan 1;6(1):123. doi: 10.1001/jamacardio.2020.5258. JAMA Cardiol. 2021. PMID: 33052381 Free PMC article. No abstract available.
Abstract
This study investigates the use of cardiac magnetic resonance imaging in competitive athletes who recovered from coronavirus disease 2019 (COVID-10) to detect myocardial inflammation that would identify high-risk athletes for return to competitive play.
Conflict of interest statement
Figures

References
-
- Maron BJ, Udelson JE, Bonow RO, et al. ; American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology . Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e273-e280. - PubMed
-
- Messroghli DR, Moon JC, Ferreira VM, et al. . Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). [published correction appears in J Cardiovasc Magn Reson. 2018;20(1):9]. J Cardiovasc Magn Reson. 2017;19(1):75. doi:10.1186/s12968-017-0389-8 - DOI - PMC - PubMed